Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Synaptic focuses on dihydropyrimidinones for BPH

Sep. 29, 1997

Design and synthesis of COX-2 inhibitors related to indomethacin

Sep. 29, 1997

SB-244875: a new bone resorption inhibitor

Sep. 29, 1997

Sumitomo prepares bone-selective bisphosphonate-estrogen conjugates

Sep. 29, 1997

Zeneca describes SAR for new asthma therapy in development

Sep. 29, 1997

Phosphomannose isomerase as target for antifungal drugs

Sep. 29, 1997

Naramig safe and effective for acute treatment of migraine

Sep. 26, 1997

Fluvastatin safely and effectively improves lipid profiles in transplant recipients

Sep. 26, 1997

Filgrastim effects on lymphocytes in HIV infection

Sep. 26, 1997

New indication for lamotrigine tested in patients: ADHD

Sep. 26, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...